Neurocrine Biosciences reported $1.71B in Equity Capital and Reserves for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 400.41M 25.27M
Acorda Therapeutics ACOR:US USD 93.62M 17.86M
Agios Pharmaceuticals AGIO:US USD 1.1B 50.64M
ALKERMES ALKS:US USD 1.04B 899K
Alnylam Pharmaceuticals ALNY:US USD -158223000 90.58M
Amgen AMGN:US USD 3.66B 8M
Aptinyx Inc APTX:US USD 48.79M 13.31M
Biogen BIIB:US USD 13.4B 622.4M
Biomarin Pharmaceutical BMRN:US USD 4.6B 34.64M
Cytokinetics CYTK:US USD -107900000 91.92M
Dynavax Technologies DVAX:US USD 581.01M 80.44M
Enanta Pharmaceuticals ENTA:US USD 300.84M 20.5M
Exelixis EXEL:US USD 2.49B 2.97M
Gilead Sciences GILD:US USD 21.21B 128M
Halozyme Therapeutics HALO:US USD 169.8M 72.81M
Intercept Pharmaceuticals ICPT:US USD 93.08M 14.6M
Intra Cellular Therapies ITCI:US USD 656.07M 29.35M
IONIS PHARMACEUT IONS:US USD 572.89M 21.47M
Nektar Therapeutics NKTR:US USD 366.64M 45.58M
Neurocrine Biosciences NBIX:US USD 1.71B 163.2M
Prothena PRTA:US USD 622.04M 217.39M
Regeneron Pharmaceuticals REGN:US USD 22.66B 1.23B
Repligen RGEN:US USD 1.91B 75.59M
Rigel Pharmaceuticals RIGL:US USD -13616000 33.45M
Sarepta Therapeutics SRPT:US USD 384.95M 45.89M
Teva Pharmaceutical TEVA:IT USD 7.9B 871M
Ultragenyx Pharmaceutical RARE:US USD 352.49M 116.34M
Vertex Pharmaceuticals VRTX:US USD 13.91B 883.1M
YTE INCY:US USD 4.37B 143.47M